Jens Juul Holst

Jens Juul Holst

Professor


  1. 2012
  2. Published

    Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine. / Kissow, Hannelouise; Viby, Niels-Erik; Hartmann, Bolette; Holst, Jens Juul; Timm, Michael; Thim, Lars; Poulsen, Steen Seier.

    In: Cancer Chemotherapy and Pharmacology. Supplement, Vol. 70, No. 1, 2012, p. 39-48.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits. / Gjesing, Anette Marianne Prior; Ekstrøm, Claus Thorn; Eiberg, Hans Rudolf Lytchoff; Urhammer, S.A.; Holst, Jens Juul; Pedersen, Oluf; Hansen, Teis.

    In: Diabetologia, Vol. 55, No. 5, 2012, p. 1338-1345.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Impact of postprandial glycaemia on health and prevention of disease. / Blaak, E E; Antoine, J-M; Benton, D; Björck, I; Bozzetto, L; Brouns, F; Diamant, M; Dye, L; Hulshof, T; Holst, J J; Lamport, D J; Laville, M; Lawton, C L; Meheust, A; Nilson, A; Normand, Signe; Rivellese, A A; Theis, S; Torekov, Signe Sørensen; Vinoy, S.

    In: Obesity Reviews, Vol. 13, No. 10, 2012, p. 923-984.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Impaired crosstalk between pulsatile insulin and glucagon secretion in prediabetic individuals. / Rohrer, Stefan; Menge, Björn A; Grüber, Lena; Deacon, Carolyn F; Schmidt, Wolfgang E; Veldhuis, Johannes D; Holst, Jens Juul; Meier, Juris J.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 5, 2012, p. E791-E795.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. / Knop, Filip K; Aaboe, K; Vilsbøll, T; Vølund, Anders; Holst, Jens Juul; Krarup, T; Madsbad, S.

    In: Diabetes, Obesity and Metabolism, Vol. 14, No. 6, 2012, p. 500-510.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. / Hansen, Katrine B; Vilsbøll, Tina; Bagger, Jonatan I; Holst, Jens Juul; Knop, Filip K.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 4, 2012, p. 1363-70.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. / Faerch, Kristine; Pilgaard, Kasper; Knop, Filip K; Hansen, Torben; Pedersen, Oluf; Jørgensen, Torben; Holst, Jens J.

    In: Diabetes, Obesity and Metabolism Online, Vol. 15, No. 1, 2012, p. 91-95.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Incretin based therapies : do they hold their promise? / Holst, Jens Juul.

    In: Journal of Diabetes, Vol. 4, No. 1, 2012, p. 4-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Leptin og dens betydning for vægtvedligeholdelse. / Iepsen, Eva Pers Winning; Torekov, Signe Sørensen; Holst, Jens Juul.

    In: Klinisk biokemi i Norden, Vol. 24, No. 4, 2012, p. 8-15.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Linagliptin, a selective DPP-4 inhibitor, inhibits DPP-4, increases incretin levels, lowers glucagon, and improves glycaemic control in patients with Type 2 diabetes. / Rauch, T; Graefe-Mody, U; Deacon, Carolyn F.; Ring, A; Holst, Jens Juul; Woerle, H-J; Dugi, KA; Heise, T.

    In: Diabetes Therapy, Vol. 3, No. 1, 2012, p. 10.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207